Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
---|---|---|---|---|---|---|---|---|---|---|---|
TSHA | Taysha Gene Therapies, Inc. | Alam Kamran | CHIEF FINANCIAL OFFICER | Feb 02, 2024 | Option Exercise | $1.51 | 1,288 | 1,945 | 840,937 | Feb 06, 2024, 04:42 PM | |
TSHA | Taysha Gene Therapies, Inc. | Alam Kamran | Chief Financial Officer | Aug 24, 2023 | Sale | $2.33 | 33,000 | 76,890 | 258,042 | Aug 25, 2023, 04:30 PM | |
TSHA | Taysha Gene Therapies, Inc. | Alam Kamran | Chief Financial Officer | Aug 23, 2022 | Sale | $3.47 | 3,325 | 11,538 | 266,121 | Aug 24, 2022, 04:47 PM | |
TSHA | Taysha Gene Therapies, Inc. | Alam Kamran | Chief Financial Officer | Aug 18, 2022 | Sale | $3.87 | 7,476 | 28,932 | 290,645 | Aug 22, 2022, 08:05 PM | |
TSHA | Taysha Gene Therapies, Inc. | Alam Kamran | Chief Financial Officer | Aug 19, 2022 | Sale | $3.75 | 11,482 | 43,058 | 279,163 | Aug 22, 2022, 08:05 PM | |
TSHA | Taysha Gene Therapies, Inc. | Alam Kamran | Chief Financial Officer | Aug 22, 2022 | Sale | $3.50 | 9,717 | 34,010 | 269,446 | Aug 22, 2022, 08:05 PM | |
TSHA | Taysha Gene Therapies, Inc. | Alam Kamran | Chief Financial Officer | Aug 20, 2021 | Sale | $16.78 | 11,840 | 198,649 | 300,215 | Aug 20, 2021, 05:52 PM | |
TSHA | Taysha Gene Therapies, Inc. | Alam Kamran | Chief Financial Officer | Aug 18, 2021 | Sale | $17.35 | 11,193 | 194,199 | 319,928 | Aug 20, 2021, 05:52 PM | |
TSHA | Taysha Gene Therapies, Inc. | Alam Kamran | Chief Financial Officer | Aug 19, 2021 | Sale | $16.47 | 9,967 | 164,175 | 310,574 | Aug 20, 2021, 05:52 PM |